Composition comprising an NK-1 receptor antagonist and an SSRI for the treatment of tinnitus and hearing loss

Details for Australian Patent Application No. 2007312209 (hide)

Owner Glaxo Group Limited

Inventors Christensen, Soren Rahn; Merlo Pich, Emilio; Ratti, Emiliangelo; Yamada, Tadataka

Agent Davies Collison Cave

Pub. Number AU-A-2007312209

PCT Pub. Number WO2008/046882

Priority 0621229.4 20.10.06 GB

Filing date 18 October 2007

Wipo publication date 24 April 2008

International Classifications

A61K 31/4525 (2006.01)

A61K 31/495 (2006.01) - having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine

A61K 31/496 (2006.01) - Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

Event Publications

7 May 2009 PCT application entered the National Phase

  PCT publication WO2008/046882 Priority application(s): WO2008/046882

28 April 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007312216-Long-term feed - cancer patient

2007312200-Traction system for operating lines, in particular mooring and/or production lines, of a floating production unit